Literature DB >> 5138342

[Studies on hepatic storage capacity and maximum transport of sulfobromophthalein in chronic kidney failure].

H Wernze, H J Spech.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5138342     DOI： 10.1007/BF01495518

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  33 in total

1.  Abnormal carbohydrate metabolism in renal disease. Blood glucose unresponsiveness to hypoglycemia, epinephrine, and glucagon.

Authors:  B D COHEN
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

2.  [Changes in bromophthalein metabolism in chronic alcoholics].

Authors:  H Rainer; H Schnack
Journal:  Wien Klin Wochenschr       Date:  1971-03-12       Impact factor: 1.704

3.  Azotemia and glucose intolerance.

Authors:  J M Cerletty; N H Engbring
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

4.  Alteration of hepatic protein synthesis in acute uremia.

Authors:  G J McCormick; L Shear; K G Barry
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

5.  Uremic serum inhibition of renal paraaminohippurate transport.

Authors:  A G White
Journal:  Proc Soc Exp Biol Med       Date:  1966-11

6.  Growth hormone in uremia. I. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uremic subjects.

Authors:  H Orskov; N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1971-02       Impact factor: 1.713

7.  Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.

Authors:  H O WHEELER; J I MELTZER; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

8.  Organic anion-binding protein in rat liver: drug induction and its physiologic consequence.

Authors:  H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.

Authors:  L J SCHOENFIELD; W T FOULK; H R BUTT
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

10.  Inhibition of protein synthesis by N-methyl-2-pyridone-5-formamidoacetic acid and other compounds isolated from uremic patients.

Authors:  E M Clayton; D Seligson; H Seligson
Journal:  Yale J Biol Med       Date:  1965-12
View more
  3 in total

1.  [Analysis of bromsulphthalein-disappearance curves, relative storage capacity, transport maximum, and 45-minutes dye retention (author's transl)].

Authors:  H J Spech; H Wernze
Journal:  Klin Wochenschr       Date:  1974-03-15

2.  [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].

Authors:  H Wernze; F Wagner
Journal:  Klin Wochenschr       Date:  1973-09-15

3.  Pharmacokinetics and biliary excretion of bromosulphophthalein, [3H]-ouabain and [3H]-taurocholic acid in rats with glycerol-induced acute renal failure.

Authors:  C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.